Contact
      Please use this form to send email to PR contact of this press release:
      
      Prolong Pharmaceuticals, Interview Released Ahead of Keynote Address at Biosimilars 2017 Summit
    
      TO:
      
      Teri Arri
      
      SMi Group
      
      2078276000